Abraham Salacata in Alpena, Michigan

Home Michigan Alpena

Abraham Salacata has Cardiovascular Disease (cardiology) listed as his primary medical specialty. Their primary office is listed as: 1501 W Chisholm St in Alpena, Michigan. They are listed as being a part of the following medical group: Midmichigan Medical Center-alpena which has, as of our last update, 52 members. You can call their office at 989-356-7242 to schedule an appointment. They also accept the Medicare-approved amount as payment in full They attended Sorry, his university is not listed and graduated in 1987 (giving them around 36 years of experience).

Abraham S Salacata Office Phone and Directions

Abraham Salacata
Midmichigan Medical Center-alpena
1501 W Chisholm St
Alpena, Michigan 49707
989-356-7242

Phone: 989-356-7242

Get mobile directions from current location:

or enter a starting address:

Healthcare Info for Abraham Salacata

Hospital Affiliations Include:
MIDMICHIGAN MEDICAL CENTER - ALPENA
MUNSON MEDICAL CENTER
MIDMICHIGAN MEDICAL CENTER-MIDLAND

Medical School: Sorry, his university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Abraham Salacata is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 36
PAC (PECOS ID)#: 7214905181
NPI #: 1255440095
NPI Created On: 08/29/2006
NPI Last Updated Listed as: 07/28/2010
Primary Taxonomy Code: 207RC0000X
First Listed License State (can have more than one): MI
License Number: AS056672
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
McLaren Health Plan Community
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Ct scan of heart blood vessels and grafts with contrast dye
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
External shock to heart to regulate heart beat
Routine ekg using at least 12 leads including interpretation and report
Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
Heart rhythm symptom-related interpretation of 24-hour ekg monitoring up to 30 days
Evaluation, testing, and programming adjustment of permanent single lead pacemaker system in one chamber of heart with qualified health care professional analysis, review, and report
Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
Evaluation, testing and programming adjustment of defibrillator with analysis, review and report
Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
Remote evaluations of defibrillator up to 90 days with analysis, review and report
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Follow-up or limited ultrasound examination of heart
Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers
Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $62

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040323

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $35

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040325

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040327

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040329

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040331

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040333

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040335

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040337

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040339

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788040341

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30